Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis
Author(s) -
Jung Tak Park,
Tara I. Chang,
Dong Ki Kim,
Jung Eun Lee,
Hoon Young Choi,
Hyunwook Kim,
Jae Hyun Chang,
So Yeon Park,
Euiseong Kim,
TaeHyun Yoo,
Dong-In Han,
ShinWook Kang
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp498
Subject(s) - medicine , metabolic syndrome , peritoneal dialysis , dialysis , continuous ambulatory peritoneal dialysis , diabetes mellitus , gastroenterology , proportional hazards model , risk factor , population , national cholesterol education program , surgery , endocrinology , obesity , environmental health
Metabolic syndrome is associated with higher morbidity and mortality in the general population, but the corresponding effects in patients on dialysis have not been clearly defined. In this study, we prospectively investigated the effect of metabolic syndrome and its individual components on outcome in non-diabetic peritoneal dialysis (PD) patients. Method. The study subjects included 106 stable non-diabetic PD patients who had been on PD for >3 months. We measured baseline characteristics, blood pressure, fasting blood glucose, lipid profiles and high-sensitivity CRP (hsCRP), and defined metabolic syndrome using the modified National Cholesterol Education Program (Adult Treatment Panel III) criteria. Mortality, technical failure and hospitalization were evaluated during the follow-up period.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom